See All Slides - tctmd.com

Slides

Presentation TCT 2013

Drug-Coated Balloons in Small Vessel Coronary Artery Disease: Synthesis of BELLO and Other Studies

Presenter: Ron Waksman

October 31, 2013

Presentation TCT 2013

Interventional, Pharmacological and Ethical Considerations in the Elderly

Presenter: Cindy Grines

October 31, 2013

Presentation TCT 2013

Case III: Periaortic PVL Closure

Presenter: Ted Feldman

October 31, 2013

Presentation TCT 2013

How Would I Treat this Patient?(10)

Presenter: Vjekoslav Tomulic

October 31, 2013

Presentation TCT 2013

The Valve Clinic Concept: Developing an Efficient and Effective Screening Process for Aortic Valve Disease Patients

Presenter: Joshua Rovin

October 31, 2013

Presentation TCT 2013

Contemporary Strategies for Congenital Valvular and Conduit Stenosis

Presenter: John P. Cheatham

October 31, 2013

Presentation TCT 2013

Cangrelor Will Be the Answer for Most in the Acute Setting!

Presenter: Robert Harrington

October 31, 2013

Presentation TCT 2013

Technical Mastery of Left Main PCI: The Do's and The Don'ts

Presenter: Andrejs Erglis

October 31, 2013

Presentation TCT 2013

Case #4: Left Main CTO in Cardiogenic Shock

Presenter: Kais Battikh

October 31, 2013

Presentation TCT 2013

GIANT: A Prospective Registry Study of CYP2C19 Genetic Profiling for Thienopyridine Management After Primary PCI in Acute Myocardial Infarction

Presenter: Bernard Chevalier

October 31, 2013

Advertisement

Slides

Drug-Coated Balloons in Small Vessel Coronary Artery Disease: Synthesis of BELLO and Other Studies

Interventional, Pharmacological and Ethical Considerations in the Elderly

Case III: Periaortic PVL Closure

How Would I Treat this Patient?(10)

The Valve Clinic Concept: Developing an Efficient and Effective Screening Process for Aortic Valve Disease Patients

Contemporary Strategies for Congenital Valvular and Conduit Stenosis

Cangrelor Will Be the Answer for Most in the Acute Setting!

Technical Mastery of Left Main PCI: The Do's and The Don'ts

Case #4: Left Main CTO in Cardiogenic Shock

GIANT: A Prospective Registry Study of CYP2C19 Genetic Profiling for Thienopyridine Management After Primary PCI in Acute Myocardial Infarction

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content